May 2021
Corporate HQ
North Carolina, US

Velocity Clinical Research is a Site Management Organisation (‘SMO’) managing clinical trial sites across North America with a focus across infectious diseases, vaccine trials and general medicine therapeutic areas.

As one of the US’s largest independent SMOs, Velocity is well recognised within the General medicine area offering access to diverse patient populations across Phase 2, 3 and post-commercialisation studies. The Company’s integrated approach benefits Sponsors, Contract Research Organisations (‘CRO’) and study participants. In addition it delivers industry leading patient enrollment and retention metrics whilst driving improvement to clinical research by enhancing site productivity, integrating study-related technologies and streamlining processes – efficiencies that can only be achieved in a wholly owned site model.

Headquartered in the US, the Company has long-term relationships with a blue chip global customer base, partnering with major CROs and sponsors globally.

Enablement & Alignment

Shared vision to continue growth trajectory and grow market leading positioning further as the stand-out international multi-site clinical trials platform.

Capability & Capacity

Decentralising clinical trials through the accelerated enhancement of virtual trial capabilities to achieve a hybrid clinical trial management model.

Building out corporate capabilities through Chief Medical Officer hire and appointing a dedicated quality and compliance team.

Building Strategic Footprints

Continued execution of North American expansion, diversifying patient sub-population and increasing customer accessibility.

Growth plan foresees continued expansion across Europe positioning Velocity as stand-out international multi-site platform.

Expanding site-level therapeutic capabilities, growing each site’s access to new studies thereby improving operational efficiencies.